3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Plasmablastic Lymphoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Hodgkin Disease
1
HIV Infections
1
Burkitt Lymphoma
1
Interventions
Radiosurgery
9
Temozolomide
8
Magnetic Resonance Spectroscopy
5
pembrolizumab
4
Specimen Handling
4
Nivolumab
4
Bevacizumab
4
Receptors, Interleukin-8B
3
Memantine
3
trastuzumab deruxtecan
2
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Radiotherapy
2
Radiation
2
Mental Status and Dementia Tests
2
Ipilimumab
2
Biopsy
2
sotorasib
1
sapanisertib
1
sacituzumab govitecan
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
elacestrant
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
carmustine, poliferprosan 20 drug combination
×
30 days
×
Clear all
No trials found.